Cue Health reports Q2 results

Healthcare technology company Cue Health reported financial results for the second quarter of 2022.

Cue Health was the first company to make an over-the-counter COVID-19 molecular diagnostic test for at-home use that received FDA approval, according to the Aug. 10 Cue news release.

Three takeaways from the report:

  1. Cue Health’s second-quarter revenue was $87.7 million.
  2. This revenue number exceeded expectations largely because of higher-than-expected COVID-19 testing orders.
  3. Private sector revenue made up 91.8 percent of Cue's second-quarter revenue.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars